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Investigating the effects of homocysteine as an agonist on invertebrate
glutamatergic synapses
Elizabeth Grau, Alexandra E. Stanback, Alec Bradley, Danielle Cantrell, Samantha
Eversole, Carolyn Grachen, Kaylee Hall, Danielle Hawthorne, Claire Kinmon, Paula Ortiz
Guerrero, Bhavik Patel, Kaitlyn Samuels, Chinni Suryadevara, Gia Valdes, Samuel Wycoff
and Robin L. Cooper
Department of Biology, University of Kentucky, Lexington, KY, USA

Hyperhomocysteinemia (HHcy) in mammals can produce neurological deficits, such as memory
loss. The cause of the neurological issues is assumed to be due to homocysteine (HCY) binding to
glutamatergic receptors in the central nervous system (CNS). High levels of HCY in the CNS are
also associated with Amyotrophic Lateral Sclerosis (ALS) and Parkinson’s disease. Thus,
understanding the detailed mechanisms of HCY in model preparations could be useful in
developing potential treatments to neurodegenerative diseases with overlapping symptoms to
HHcy. The aim of this study is to investigate the efficacy of HCY as an agonist at glutamatergic
synapses in invertebrates. The glutamatergic synapses of the larval Drosophila melanogaster (D.
melanogaster) and Procambarus clarkii (P. clarkii) neuromuscular junctions (NMJs) were utilized
to examine the effects of applying HCY. Measurements of evoked synaptic transmission in both
preparations revealed that 100 mM of HCY did not have any consistent effect. The expectation
was that the acute action of HCY would have activated the glutamate receptors and then
desensitized them so evoked transmission would be blocked. The pharmacological receptor profile
of these NMJ receptors are of a quisqualate subtype and not a kainate, α-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA) or N-methyl-D-aspartate receptor (NMDA) subtype.
Consequently, HCY may not have any action on quisqualate glutamate receptor subtypes. The
findings of this experiments could provide clinical implications regarding relevant
pharmacological treatments in neurodegenerative diseases such as amyotrophic lateral sclerosis
(ALS) and Parkinson’s disease.

Abbreviations: ACURE— authentic course-based undergraduate research experience; AMPA—
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; EPSP— excitatory
postsynaptic potential; HCY— homocysteine; HHcy— Hyperhomocysteinemia; NMDA— Nmethyl-D-aspartate receptor; NMJ— neuromuscular junction
Keywords — ACh, glutamate, Homocysteine, Drosophila melanogaster, invertebrate,
pharmacology, Procambarus clarkii, receptor
_____________________________________________________________________________________

Introduction
Homocysteine (HCY) is an amino acid
intermediate produced in the central nervous
system (CNS) in the metabolism of methionine to
cysteine. The actions of HCY in mammals and
the associated pathological state of high plasma
HCY levels, known as hyperhomocysteinemia

(HHcy), in part, revolve around the actions of
HCY on glutamatergic receptors (Lipton et al.,
1997; Poddar and Paul, 2013; Abushik et al.,
2014; Bukharaeva et al., 2015). Glutamate is an
excitatory neurotransmitter that acts at
glutamatergic receptors, particularly N-methylD-aspartic acid (NMDA) receptors. HCY is

Page 2 of 10
Impulse: The Premier Journal for Undergraduate Publications in the Neurosciences
2018

produced in the CNS and can act as an excitatory
transmitter activating both NMDA and nonNMDA glutamate receptors in mammalian
models. In this study we examined the potential
action of HCY on the non-NMDA glutamate
receptors. In particular, we tested the action of
HCY on the quisqualate receptor subtype which
is of a non-NMDA subtype Even at the
acetylcholine (Ach) transmitting neuromuscular
junctions (NMJs) of mammals, it has been
established that there are NMDA receptor
subunits which are affected by HCY (Bukharaeva
et al., 2015).
Glutamate receptors are defined as
NMDA (N-methyl-D-aspartic acid) and nonNMDA subtypes (i.e., AMPA, kainate, δ and
quisqualate) based on their pharmacological
sensitivity (Lee et al., 2009). The importance of
the receptor subtypes is in understanding the
action of the cells expressing them. NMDA
receptors are ionotropic and allow an influx of
Ca2+ ions when open, which can lead to a number
of cellular responses and even cell death
(Verdoorn et al., 1991). Kainate receptors in
mammals are of a metabotropic subtype and work
through second messenger cascades. They are
even known to be present on presynaptic nerve
terminals to reduce evoked transmitter release via
autoreceptors on the presynaptic terminals (Park
et al., 2006). NMDA and kainate subtypes
produce a lower percentage of desensitization
than the quisqualate receptor subtype (Thio et al.,
1991). The compounds kainate, NMDA and
AMPA do not activate the glutamate ligand gated
ion channels at the larval Drosophila
melanogaster (D. melanogaster) NMJ but
quisqualate does (Bhatt and Cooper, 2005; Dudel
et al., 1992) (
The action of HCY at the mammalian
NMJs can be blocked by application of the
glutamate
competitive
antagonist
AP-5
(Bukharaeva et al., 2015). Additionally, there is a
strong correlation with HHcy in mammals with
high plasma and cerebrospinal fluid levels of
HCY to the motor neuronal disease, amyotrophic
lateral sclerosis (ALS) (Bukharaeva et al., 2015;
Veeranki and Tyagi, 2013). Over-activation of

glutamatergic drive on motor neurons has been
shown to facilitate the disease state of ALS
through subsequent degradation of the motor
neurons (Vucic and Kiernan, 2009). Riluzole, a
glutamatergic antagonist within the central
nervous system (CNS), works as an effective
treatment in ALS patients through reduction of
glutamatergic activation on motor neurons
(Vucic and Kiernan, 2009; Miller et al., 2012;
Doble, 1996). As highlighted by Yohay et al.,
(2014), Riluzole also doubles as an effective
treatment in rodent models of CNS injury as well
as neurodegenerative states such as Parkinson’s
disease. Thus, HCY has the potential to maybe
act similarly to Riluzole for potential treatments.
HCY has also been shown to restore
sensitization of glutamatergic receptors in rodent
neurons, which may account for the larger ionic
currents of the glutamate receptors (Bolton et al.,
2013). It has been demonstrated that an enzyme
deficiency
in
rodents
of
methylenetetrahydrofolate reductase leads to an
increase in neuronal damage by HCY and results
in an increase in γ-aminobutyric acid (GABA)
within the CNS which is assumed to compensate
for the higher HCY levels (Jadavji et al., 2015).
Also, HCY has an antagonistic action on GABA
receptors (Tyagi et al., 2005). The actions on
GABA receptors could, in part, account for the
effect of HCY and the resulting pathologies in
mammals exhibiting HHcy (Tyagi et al., 2005).
GABA is an inhibitory receptor subtype,
conducting actions via G-proteins to limit Ca2+
within the cell during synaptic transmission
(Olsen and DeLorey, 1999). Antagonistic actions
of HCY on GABA receptors could result in
prevention of inhibition of glutamatergic receptor
action. Therefore, the result of such an interaction
could be the production a summative excitatory
response that would contribute to neuronal death
and subsequent blood brain barrier degradation
experienced in the presence of excess HCY.
How the precise mechanisms of action of
HCY on various neurotransmitter receptors and
synaptic transmission may be altered are still
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being investigated. It is established that HCY can
act on both NMDA and non-NMDA receptors in
rodent models (Yuzaki and Connor, 1999). The
glutamatergic NMJs of larval D. melanogaster
and Procambarus clarkii (P. clarkii) are of a nonNMDA subtype. Given that HCY is known to be
synthesized in D. melanogaster (Caggese et al.,
1997), it is likely it is present in other arthropods
such as the crayfish P. clarkii. The investigations
to date are primarily focused on mammalian CNS
models; however, some aspects of precise quantal
measures of synaptic transmission are more
challenging in mammalian models compared to
those at invertebrate NMJs. This difference is
due to the ability to record at synaptic sites in
invertebrate models. Furthermore, the potential
effects of HCY on synaptic facilitation and
synaptic depression have not been thoroughly
investigated in mammalian models.
However, such information could
provide clinical implications regarding diseases
that have been shown to exhibit relationships
with HCY pathology, such as Parkinson’s disease
and ALS. Thus, the purpose of this experiment is
to gain insight into the mechanisms of action of
HCY at the NMJs of model organisms. These
experiments were designed to test the prediction
that application of HCY to model systems would
produce an initial
overstimulation of
glutamatergic receptors followed by quick
desensitization.
P. clarkii NMJs have served as a classic
model in glutamatergic synaptic facilitation and
depression (Richet, 1879; Katz, 1949; Sherman
and Atwood, 1971; see recent reviews Cooper
and Cooper, 2009; Titlow and Cooper, 2018). D.
melanogaster NMJs have also been utilized for
the same purpose due to their utility as a genetic
model for mutational defects in synaptic
transmission afflicting humans (Jan and Jan
1976a,b; Usherwood, 1977; DiAntonio, 2006;
see recent review Titlow and Cooper, 2018). In
addition, the P. clarkii NMJs have both
glutamatergic and GABA-ergic innervation
profiles, (Bazemore et al., 1956; Van Harreveld

and Mendelson, 1959; Dudel and Kuffler, 1961a;
Florey, 1961) which are used for assays of
pharmacological agents (Van Harreveld
1959,1980; Shinozaki and Ishida, 1981a,b,c;
Shinozaki et al., 1982; Bhatt and Cooper, 2015;
Lee et al., 2009). Alterations in both quantal
amplitudes and area of quantal shapes are
indicative of action on fundamental synaptic
properties by neurotransmitters. These are readily
measured at P. clarkii and larval D. melanogaster
NMJs (Cooper et al., 1995).
Both preparations produced graded
evoked responses which are related to the
synaptic efficacy of multiple quantal fusion
events and spontaneous single quantal events.
These are readily obtained with intracellular and
extracellular recordings on identifiable muscle
fibers (Dudel and Kuffler, 1961b; Pawlu et al.,
2004). Thus, these two model synaptic
preparations were utilized in this study to further
assess the effects of HYC on synaptic
transmission. Any changes in the amplitude of
evoked excitatory postsynaptic potentials
(EPSPs) were investigated for HYC effects on
glutamate receptors at these two model NMJs. To
investigate
any
potential
presynaptic
contributions by HYC and the influence of Ca2+
on facilitation and depression, varied
concentrations of Ca2+ in bathing saline were
used with exposure to HYC. This study was
designed and executed with the intention of
progressing understanding of the mechanistic
actions of HCY on glutamatergic non-NMDA
receptors. Such information could be utilized to
provide improved treatment of HHcy pathologies
and symptoms, including difficulty forming new
memories, therefore providing a deeper
understanding of neuropathologies such as
Alzheimer’s disease and Parkinson’s disease.

Material and Methods
Animals
Both P. clarkii and D. melanogaster
glutamatergic were utilized. These synapses are
commonly used to assay pharmacological agents.
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The graded EPSPs of the P. clarkii opener NMJ
are easier to measure reliably when the responses
are facilitated to obtain an amplitude of the
synaptic responses above the noise level. Thus,
ten stimuli delivered at 40 Hz produces a
reasonable EPSP response for the 10th response to
measures (Figure 1A). The changes over time
were measured by change in response of the 10 th
EPSP during exposure to HCY (100 µM). A
representative preparation in which the EPSPs
were monitored over time is illustrated (Figure
1B).

between trains. An average of 20 trains in each of
the conditions was used for measures of EPSPs.
Preparations were not stimulated during control
periods to obtain spontaneous quantal events.

Experiments were performed using P.
clarkii, measuring six– eight cm in body length
(obtained from Atchafalaya Biological Supply
Co., Raceland, LA, USA). Six P. clarkia were
individually stored in an aquatic facility at room
temperature (20-21°C) and were fed commercial
fish food pellets (Aquadine) for at least two
weeks prior to experimentation.
The general maintenance in culturing
Drosophila as well as staging of instars and the
developmental cycle are described in CamposOrtega and Hartenstein (1985). All animals were
maintained in vials partially filled with a
cornmeal-agar-dextrose-yeast
medium
as
described in Cooper and Cooper (2004). Wild
type Canton S (CS) flies were used for analyses
via the semi-intact method. This method involves
cutting along the dorsal midline to expose the
body wall muscles and the nervous system
(Stewart et al., 1994). This Drosophila strain has
been isogenic in the lab for several years and was
originally obtained from Bloomington Fly Stock.
To obtain 3rd instar staged larvae, the larvae were
held at 25 °C in a 12 h light/dark incubator before
being selected.
Electrophysiological recordings of NMJs in P.
clarkii
In brief, the excitatory neuron is isolated
from the inhibitor neuron and stimulated in the
meropodite segment. The most distal fibers of the
opener were always used for recording synaptic
responses (Figure 2A). The stimulation paradigm
consisted of providing a train (series of electrical
pulses) of 20 pulses at 40 Hz with ten seconds

Figure 1: The effects of homocysteine (HCY) on the
glutamatergic synaptic responses at the P. clarkii
neuromuscular junction. (A) The amplitude of tenth EPSP
produced by 40Hz stimulation is used as an index of
synaptic transmission. (B) A representative response from
a preparation in which the tenth EPSP is monitored before
and during the exposure to HCY (100 µM). The box
outlines indicate the time period used to obtain a mean
amplitude of the EPSPs to be used to calculate percent
differences in amplitude due to exposure to HCY. (C) The
mean amplitude of the EPSPs before and during exposure
to HCY for each of the six preparations. (D) The mean
percent difference in the six preparations obtained before
and during exposure to HCY. No significant effect in EPSP
amplitude was noted due to exposure to HCY.

Dissected preparations were maintained
in saline; a modified van Harreveld’s solution (in
mM: 205 NaCl, 5.3 KCl, 13.5 CaCl2·2H2O, 2.45
MgCl2·6H2O, and 5 HEPES adjusted to pH 7.4).
All the experiments were performed at room
temperature. Intracellular recordings were made
with a sharp glass electrode filled with 3.0 M
KCl, and both recorded and analyzed via Scope
and LabChart software (AD Instruments). The
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Figure 2: The P. clarkii and larval D. melanogaster
preparations. (A) The most distal muscle fibers of the P.
clarkii opener muscle in the first walking leg provides a
common target among preparations. The opener muscle
does show regional differences in amplitudes of EPSPs.
The excitatory motor neuron is selectively stimulated in
a more proximal segment of the leg while monitoring the
EPSPs produced. (B) The body wall muscle named m6 of
the third or fourth segments in the dissected early third
instar larvae are used to measure the evoked EPSP. Body
wall muscle m6 and m7 are shown in each segment. The
segmental nerve to the segment of interest is stimulated
with a suction electrode which contains the segmental
nerve.

amplitudes of the EPSPs spontaneous quantal
events (mEPSPs) elicited by the motor nerve
were recorded. Intracellular responses were
recorded with a 1 x LU head stage and an
Axoclamp 2A amplifier (Molecular Devices,
Sunnyvale, CA, USA). HCY was made fresh in
the physiological saline the day of
experimentation. All chemicals were obtained
from SIGMA-Aldrich (St. Louis, MO, USA).
Electrophysiological recordings of NMJs in
larval Drosophila
The synaptic responses at the larval D.
melanogaster NMJs were recorded by standard
procedures (Lee et al., 2009) with stimulation at
0.5 Hz (Figure 2B). The modified HL3 saline was
used for physiological measures (Stewart et al.,
1994) at a pH of 7.1 (de Castro et al., 2014).
Saline solution (in mM): 1.0 CaCl2·2H2O, 70
NaCl, 20 MgCl2, 5 KCl, 10NaHCO3, 5 trehalose,
115 sucrose, 25 5N,N-bis(2-hydoxyethyl)-2aminoethanesulfonic acid (BES)) was utilized.

HCY (100 µM) was made fresh in the
physiological saline the day of experimentation.
All the experiments were performed at room
temperatures (20–21◦C). EPSPs were measured
by intracellular recordings with a sharp glass
electrode (3 M KCl) and AxoClamp-2 B
amplifier (Molecular Devices, Sunnyvale, CA,
USA). Stimulations were made with a Grass S88
dual stimulator (Natus Neurology Incorporated,
Middleton, WI, USA). Preparations were used
immediately after dissection. Electrical signals
were recorded online to a computer via a
PowerLab/4s interface (AD Instruments,
Colorado Springs, CO, USA). Seven larval D.
melanogaster preparations were dissected as
previously described (Li et al., 2001) for early
third instars. Each D. melanogaster preparation
was used to measure EPSPs in the same muscle
fiber in both saline and in the presence of HCY,
therefore giving a baseline control for that
individual preparation. All chemicals were
obtained from Sigma-Aldrich (St. Louis, MO).
All measures were made in muscle six of
segments three or four.
Statistical analysis
All data are expressed as an average
value along with the standard error of the mean
(i.e., + SEM). The rank sum pairwise test or a sign
test was used to compare the differences in
responses before and after exchanging a solution
with saline containing the compounds. This
analysis was performed with Sigma Stat
software. P of < 0.05 is considered to be
statistically significant.

Results
To examine for an effect due to exposure
to HCY, the mean amplitude of the tenth EPSP
from an average of at least 20 responses was
compared during saline exposure and during
HCY exposure (Figure 1C). The percent
difference in each of the six preparations before
and during exposure to HCY revealed no
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significant trend (P > 0.05, sign test) to an effect
on the EPSP amplitude at the P. clarkii NMJ
(Figure 2D). The mean percent difference was
1.33 (4.8+/- SEM).

exposure. The mean amplitudes for each of the
seven preparations before and during exposure to
HCY is shown (Figure 3C). The percent
difference in the seven preparations before and
during exposure to HCY revealed no significant
trend (P > 0.05, sign test) in an effect on the EPSP
amplitude at the larval D. melanogaster NMJ
(Figure 3D). The mean percent difference was
0.13 (4.2+/- SEM).

Discussion

Figure 3: The effects of homocysteine (HCY) on the
glutamatergic synaptic responses at the larval D.
melanogaster neuromuscular junction. (A) The
amplitude of the EPSP used as an index of synaptic
transmission. (B) A representative response from a
preparation in which the EPSP is monitored before and
during the exposure to HCY (100 µM). The box outlines
indicate the time period used to obtain a mean amplitude
of the EPSPs to be used to calculate a % differences in
amplitudes due to exposure to HCY. (C) The mean
amplitude of the EPSPs before after during exposure to
HCY for each of the seven preparations. (D) The mean
percent difference in the seven preparations with before
and during exposure of HCY. No significant effect is
noted due to exposure of HCY.

The graded evoked response at the larval
D. melanogaster NMJ on muscle 6 produced a
large enough EPSP that facilitation of the
synaptic response was not necessary as for the P.
clarkii opener NMJs (Figure 3A). The amplitude
of the EPSPs over time for a representative
preparation illustrated that no large changes
occurred upon exposure to HCY (100 µM)
(Figure 3B). The blocked regions in the trace
indicated the region of time used to calculate the
mean EPSP amplitude used for quantification in
determining a percent change due to HCY

In this study, we demonstrated that HCY
at 100 µM did not have any effect on synaptic
transmission at the NMJs of the P. clarkii and
larval D. melanogaster. This differed from our
hypothesis that application of HCY to
glutamatergic synapses in D. melanogaster and
P. clarkii would be inhibited by a high HCY
concentration via competition for the release of
glutamate at the NMJ. Despite these
glutamatergic synaptic preparations having nonNMDA receptor subtypes postsynaptically, and
that it was established that HCY could influence
non-NMDA receptors in mammalian CNS
preparations (Yuzaki and Connor, 1999), no
detectable differences in the amplitude of the
evoked EPSPs could be ascertained. It is likely
the extracellular domain of the quisqualate
subtype glutamate receptors of the P. clarkii and
larval D. melanogaster NMJs is significantly
divergent such that they are unreceptive to HCY
(Lee et al., 2009). It is known that the GluN2A
subunit of the NMDA receptors is key to HCY
having an effect (Sibarov et al., 2016).
Potentially, the extracellular domains of the
different receptor make up could be compared
with bioinformatics to estimate the 3-dimensional
configuration required for HCY sensitivity. It is
known that exposure to the P. clarkii or larval D.
melanogaster NMJs to 100 µM of glutamate that
depolarization will occur followed by
desensitization and a reduce amplitude in the
evoked EPSP (Lee et al., 2009; Titlow and
Cooper, 2018). So, if HCY was to act as an
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agonist we would have expect some alteration in
response at a similar concentration.
The lack of an acute or longer term effect
by HCY at such high concentration is most likely
explained that the glutamate receptors on both
preparations is not sensitive to HCY. If one was
interested in knowing the precise structural
elements required for HCY to have an action,
various glutamate receptors subunits, with
sequence alterations, could be expressed in a cell
line or frog oocytes and examined for responses
to HCY.
In mammals, HCY acts on the CNS to
alter various functions such as sympathetic
activity, and may even be related to inducing
cardiovascular pathologies (Zhong et al., 2017).
The physiological profiling of the glutamatergic
receptors within the CNS or the equivalent
ventral nerve cord of larval D. melanogaster and
P. clarkii has not been performed. Perhaps there
may be actions of HCY on the central
glutamatergic synapses in these invertebrate
preparations as for mammals. Further studies will
need to be conducted to determine if these
invertebrate models have similar central
responses to HCY as mammals.
Since D. melanogaster are known
synthesize HCY, (Caggese et al., 1997) it is
probable other insects and crustaceans synthesize
it as well due to physiological and biochemical
similarities between species of arthropods. The
crustaceans are similar to insects in many ways
related to neural function. At this point,
investigations have yet to be conducted to
determine if HCY is present in the CNS of
crustaceans. However, one of the proposed longrange treatments by health food supplement aids
for HHcy in humans is to have a diet high in
marine crustaceans (Tou et al., 2007; Naushad et
al., 2017) as it has been shown that a diet of Arctic
krill for rodents reduces HCY levels in the blood
(Bjørndal et al., 2015). We could not find any
scientific studies using humans to directly show
that a diet of marine crustaceans was beneficial

for human treatment of HHcy pathologies. The
mechanisms in the rodents for reducing HCY is
most likely due to the n-3 polyunsaturated fatty
acids in the muscle and vitamins B12, B6, and
folate in krill (Bjørndal et al., 2015;
Krajcovicová-Kudlácková and Blazícek, 2002).
Future studies would be of interest to
determine any potential central effects of HCY in
invertebrates, particularly D. melanogaster, as
genetic models of degradation of HCY could
potentially be utilized to look at long term
consequences on neural development with raised
HCY as it relates to consequences in mammals.
As a comparative investigation, it would be of
interest to know if crustaceans also produce HCY
in the CNS. This could be determined through
analysis of HCY levels in varied areas of interest
within the CNS, such as the hippocampus and
blood-brain barrier both at baseline neural
stimulation and in differing states of stimulation.
Also of interest would be to determine if an
altered diet, such as with vitamin B complexes,
would lower HCY in the CNS of D.
melanogaster, thus furthering implicating a
relationship in diet, HCY levels, and possible
resultant neuroprotective or neurodegenerative
responses. The understandings that would be
provided by these further elaborations of this
experiment could translate to development of
treatments of aforementioned diseases such as
Parkinson’s disease and ALS at a much later
point.
The results of this experiment lead to
several possible implications regarding the
clinical relevance of using P. clarkii and D.
melanogaster as models for HHcy and diseases
with similar pathologies. However, utility of
these preps remains useful for establishing a basic
understanding of HCY action at glutamatergic
receptors, but subsequent experiments attempting
to draw conclusions regarding clinical
application would require a model with a subtype
of glutamatergic receptors that is more similar to
those found in mammals.
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Endnotes
Many of the authors were students in a
neurophysiology lab based class who addressed
authentic scientific based questions in regard to
the topic of examining pharmacological agents
known in other models to block stretch activated
ion channels. This course project is part of a trend
in teaching science to undergraduates (Linn et al.,
2015). Course-based undergraduate research
experiences (CUREs) are an approach being
adopted by science educators in high schools and
colleges (Bakshi et al., 2016). Our hope is to
present a new acronym for authentic coursebased undergraduate research experience
(ACURE).
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